Thyroid Malignancy and Low Serum Calcium Explanation

The question asks for the most likely reason for low serum calcium in a 75-year-old patient with thyroid malignancy.

Medullary Carcinoma Link to Hypocalcemia

Medullary thyroid carcinoma (MTC) is a specific type of thyroid cancer that arises from the parafollicular C-cells of the thyroid gland. These C-cells normally produce calcitonin.

• Calcitonin Function: Calcitonin is a hormone that acts to lower serum calcium levels. It inhibits osteoclast activity (reducing bone resorption) and decreases calcium reabsorption in the kidneys.
• MTC and Calcitonin: In MTC, these C-cells become malignant and often overproduce calcitonin. This excess calcitonin leads to a significant decrease in serum calcium, resulting in hypocalcemia.

Analysis of Other Options

Other types of thyroid cancer and potential complications are less likely explanations for low serum calcium:

• Metastasis to parathyroid: While possible, metastasis *to* the parathyroid glands causing significant damage leading to hypocalcemia is less common than MTC directly causing it via calcitonin. Destruction of parathyroids leads to low calcium, but this specific scenario is less probable than the MTC mechanism.
• Follicular carcinoma and Papillary carcinoma: These are the most common types of thyroid cancer. They do not typically secrete hormones that directly lower serum calcium. While extensive bone involvement in any cancer can sometimes lead to hypercalcemia, they are not primarily associated with causing hypocalcemia.

Conclusion

Given that Medullary carcinoma directly causes excess calcitonin secretion, which lowers serum calcium, it is the most likely explanation for the patient's hypocalcemia among the choices provided.